2021 news

The University of York is one of seven founding partners to establish the new Centre for Early Mathematics Learning (CEML).

A Hull York Medical School Professor is leading a study to develop a controlled human infection model to pave the way for testing new vaccines against the neglected disease leishmaniasis.

Scientists have revealed how bacteria make tiny liquid droplets from proteins to help them survive harsh environments and thus reduce their chances of being killed by antibiotics.

Biology PhD researcher Theo Issitt heads to Berlin in November after beating off strong competition to win a place in the final of the international Falling Walls ‘Emerging Talent’ competition.

The University of York is to collaborate with diagnostics development specialists Cizzle Biotechnology to develop a blood test to detect lung cancer.

Professor Gideon Davies has been awarded a further five year term for his prestigious Royal Society Ken Murray Research Professorship.

York researchers are leading a team that will receive £450k to create the world's first high throughput two-dimensional infrared (2D-IR) screening facility for the pharmaceutical and healthcare sectors.

A major new consortium involving the University of York has been awarded £6.8 million by the National Institute of Health Research (NIHR) to conduct the largest clinical study of long COVID over the next two years.

The University of York Three Minute Thesis (3MT) competition challenges PhD students to educate and engage the audience with their research in just three minutes.

Leading scientists from the University of York will share their research with a global audience as part of the Royal Society’s 2021 Summer Science digital showcase.

The University of York has won a share of £79m to train the next generation of researchers to tackle some of the major health problems facing the population.

Researchers at Hull York Medical School are part of a team set to undertake major research aimed at improving the treatment of people with blood cancers

Two projects could have crucial findings for developing new antibiotic treatments and slowing the spread of antibiotic resistance.

An international team of researchers have shed new light on the early stages of viral evolution.

Researchers in the Departments of Physics and Electronic Engineering have received almost £1m to develop a device to enable patients to self-assess their immune systems at home.

Scientists have identified a promising vaccine candidate for a parasitic disease that causes a chronic wasting disease in livestock animals across sub Saharan Africa.

The University of York is hosting a trial of a new COVID-19 vaccine.

A University ‘spin-out’ company is the first at York to be listed on the London Stock Exchange (LSE).

The University of York and its partners have received £4.2m to revolutionise the cells used to produce biological drugs and increase their cost-effectiveness.

The results of the first clinical trial of a new vaccine for a neglected tropical disease have demonstrated that it is safe and induces immune responses in patients with the infection.

The York Unlimited campaign of the University of York is aiming to transform mental health on a local, national and international scale, through supporting on the ground initiatives and the latest groundbreaking research.

Researchers at York have shed new light how the Leishmania parasite controls the way in which it survives in its insect vector and mammalian host.

Congratulations to Dawn Coverley on her recent successful funding award.

Researchers believe they may have discovered a possible cause of a mystery condition that can leave sufferers suddenly unable to walk, talk or see.

Dr David Kent was recently awarded a Cancer Research UK Programme Foundation Award of £1.5 million over six years to continue his research on blood cancers.

Scientists in the Jack Birch Unit (JBU) have been fundraising for York Against Cancer by participating in a 50km challenge in March 2021.

Videos allowing us to see for the first time how small circles of DNA adopt dance-like movements inside a cell have been developed by researchers at universities in Yorkshire.

A new technology developed in the Department of Chemistry can fabricate injectable biocompatible microgels, with sub-micrometre diameters, that can release bioactive agents and hence enhance stem cell growth.

Researchers have taken an important step forward in developing a controlled human infection model to test leishmaniasis vaccines.

A research technique developed at the University of York could help clinicians identify the best antibiotic to treat common conditions such as urinary tract infections.

PREV_PKDL is a €8M collaborative project funded by the European & Developing Countries Clinical Trials Partnership (EDCTP2) Programme supported by the European Union. The project is the joint effort of leading European and African experts with proven track records in research and development of products against leishmaniasis.

Researchers at York are to collaborate with a leading specialist in the field of deubiquitylase (DUB) enzymes in the fight against Leishmaniasis disease. DUBs are part of an essential protein degradation pathway in cells that use a process called ubiquitination.